Cite
HARVARD Citation
Flaherty, K. et al. (2017). Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease. BMJ open respiratory research. 4 (1), p. . [Online].